There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Despite the evident success stories, the adoption of AI/ML in chemical engineering faces unique challenges. Unlike consumer applications where vast data sets are readily available, chemical processes ...

The Company's cash, cash equivalents and short-term investments balance as of March 31, 2025, was $66.3 million compared with $52.8 million at the end of the prior quarter. Long-term borrowings ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...